Biosimilars Market 2019-2025: Industry Analysis, Geographical Segmentation, Drivers, Challenges, and Trend & Forecasts

Global biosimilars market report gives comprehensive outlook on biosimilars products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on biosimilars market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, manufacturing type, distribution channel, and geographic regions. Global biosimilars market estimated to be valued US$ 4.10 Bn in 2018 and poised to grow at CAGR of 23.0% over 2019-2025. Market for biosimilars projected to reach US$ 14.23 Bn by 2025 owing to increasing patent expires of biologics and rising biosimilars product pipeline.

Major Key Players of the Biosimilars Market are:
Amgen Inc. (U.S.), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (U.S.), Samsung Bioepis (South Korea), Novartis AG (Switzerland), Teva Pharmaceuticals Industries Ltd. (Israel)

Read More @ http://themarketpublicist.com/2020/06/11/biosimilars-market-2019-2025-industry-analysis-geographical-segmentation-drivers-challenges-and-trend-forecasts/ 


Comments

Popular posts from this blog

How Have AI and Machine Learning Reshaped the Fire Alarm and Detection System Industry in 2024?

How is Quantum AI Accelerating the Drug Discovery Process?

Strategic Developments in Semiconductor Foundry Technologies and Their Global Impact